 The primary objective to determine the difference in dopamine D2 occupancy of ziprasidone at expected peak plasma levels 6 hours and 12 and 24 hours postdose. The secondary objectives are to compare ED50 the plasma levels of ziprasidone resulting in 50 maximal receptor occupancy 24 hours postdose with those 6 and 12 hours postdose. 